Physician

Ramin Rahimi, D.O.

According to 2025 Medicare claims, Ramin Rahimi, D.O. (NPI: 1639146624) practices physical medicine and rehabilitation in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is WEST MICHIGAN REHAB PLLC (NPI: 1851588859; TIN: 383455993) and primary practice location at 49525-1003. Rahimi is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626) and Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Rahimi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 166 traditional Medicare patients, billed 7,194 HCPCS/CPT codes, and received $182,185 in Medicare payments. The top billing code was 97162 (Evaluation for physical therapy, typically 30 minutes). Part D data shows 1,539 prescription claims across 361 beneficiaries totaling $53,132 in drug costs, led by Lidocaine-Prilocaine (Lidocaine/Prilocaine). DME data shows 25 claims. Open Payments data shows 11 records totaling $256. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $286,793 to $182,185. Similarly, Part D prescription costs have fallen sharply in recent years, from $146,284 to $53,132. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,694 to $934.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$156K$313K2015 Medicare payment: $286,793 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $233,851 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $255,053 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $312,984 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $306,554 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $204,592 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $236,575 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $203,417 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $201,362 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $182,185 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201525113,022$286,793
201622413,062$233,851
201721020,700$255,053
201825420,611$312,984
201918922,627$306,554
202015613,668$204,592
202115117,280$236,575
202213710,248$203,417
20231388,071$201,362
20241667,194$182,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$81K$161K2015 Drug cost: $146,284 (USD; Tot_Drug_Cst)2016 Drug cost: $132,105 (USD; Tot_Drug_Cst)2017 Drug cost: $143,655 (USD; Tot_Drug_Cst)2018 Drug cost: $156,587 (USD; Tot_Drug_Cst)2019 Drug cost: $161,152 (USD; Tot_Drug_Cst)2020 Drug cost: $130,614 (USD; Tot_Drug_Cst)2021 Drug cost: $136,557 (USD; Tot_Drug_Cst)2022 Drug cost: $57,394 (USD; Tot_Drug_Cst)2023 Drug cost: $44,721 (USD; Tot_Drug_Cst)2024 Drug cost: $53,132 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152902,638$146,284
20162442,165$132,105
20172622,124$143,655
20182642,335$156,587
20192662,720$161,152
20202742,901$130,614
20212733,686$136,557
20222951,383$57,394
20232631,023$44,721
20243611,539$53,132

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$25K2015 Medicare payment: $3,752 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,443 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $626 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,080 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $21,258 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $25,398 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $22,135 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $22,250 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $15,006 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R38$3,752
2016N/R35$2,443
2017N/R11$626
2018N/RN/RN/R
20191213$9,080
20202031$21,258
20214762$25,398
20223637$22,135
20233838$22,250
20242525$15,006

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
97162Evaluation for physical therapy, typically 30 minutes5665$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more99399$58
80307Testing for presence of drug, by chemistry analyzers81495$57
97110Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes63257$17
97140Therapy procedure using manual technique, each 15 minutes681,274$15

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Lidocaine-PrilocaineLidocaine/Prilocaine951,530$7,619
BuprenorphineBuprenorphine35982$6,095
SavellaMilnacipran Hcl12360$5,398
Tizanidine HclTizanidine Hcl1003,530$4,367
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl46953$3,850

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0651Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelfN2525$15,006

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$256Collegium Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ramin Rahimi, D.O.?

Tedicare shows public-source Medicare data for Ramin Rahimi, D.O. (NPI 1639146624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramin Rahimi, D.O. have ACO affiliation data?

Ramin Rahimi, D.O. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626) and Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Ramin Rahimi, D.O.?

Ramin Rahimi, D.O. is linked to WEST MICHIGAN REHAB PLLC (billing NPI 1851588859) in the available physician profile data.

Does Ramin Rahimi, D.O. have Open Payments data?

Ramin Rahimi, D.O. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.